Top

BMC Public Health

Published in:

Open Access 01-12-2022 | Research

Higher blood nicotine concentrations following smokeless tobacco (pituri) and cigarette use linked to adverse pregnancy outcomes for Central Australian Aboriginal pregnancies

Authors: Angela Ratsch, Fiona Bogossian, Elizabeth A. Burmeister, BoMi Ryu, Kathryn J. Steadman

Published in: BMC Public Health | Issue 1/2022

Abstract

Background

In central Australia, Aboriginal women use wild tobacco plants, Nicotiana spp. (locally known as pituri) as a chewed smokeless tobacco, with this use continuing throughout pregnancy and lactation. Our aim was to describe the biological concentrations of nicotine and metabolites in samples from mothers and neonates and examine the relationships between maternal self-reported tobacco use and maternal and neonatal outcomes.

Methods

Central Australian Aboriginal mothers (and their neonates) who planned to birth at the Alice Springs Hospital (Northern Territory, Australia) provided biological samples: maternal blood, arterial and venous cord blood, amniotic fluid, maternal and neonatal urine, and breast milk. These were analysed for concentrations of nicotine and five metabolites.

Results

A sample of 73 women were enrolled who self-reported: no-tobacco use (n = 31), tobacco chewing (n = 19), or smoking (n = 23). Not all biological samples were obtained from all mothers and neonates. In those where samples were available, higher total concentrations of nicotine and metabolites were found in the maternal plasma, urine, breast milk, cord bloods and Day 1 neonatal urine of chewers compared with smokers and no-tobacco users. Tobacco-exposed mothers (chewers and smokers) with elevated blood glucose had higher nicotine and metabolite concentrations than tobacco-exposed mothers without elevated glucose, and this was associated with increased neonatal birthweight. Neonates exposed to higher maternal nicotine levels were more likely to be admitted to Special Care Nursery. By Day 3, urinary concentrations in tobacco-exposed neonates had reduced from Day 1, although these remained higher than concentrations from neonates in the no-tobacco group.

Conclusions

This research provides the first evidence that maternal pituri chewing results in high nicotine concentrations in a wide range of maternal and neonatal biological samples and that exposure may be associated with adverse maternal and neonatal outcomes. Screening for the use of all tobacco and nicotine products during pregnancy rather than focusing solely on smoking would provide a more comprehensive assessment and contribute to a more accurate determination of tobacco and nicotine exposure. This knowledge will better inform maternal and foetal care, direct attention to targeted cessation strategies and ultimately improve long-term clinical outcomes, not only in this vulnerable population, but also for the wider population.

Note to readers

In this research, the central Australian Aboriginal women chose the term ‘Aboriginal’ to refer to themselves, and ‘Indigenous’ to refer to the broader group of Australian First Peoples. That choice has been maintained in the reporting of the research findings.

Available only for authorised users

World Health Organisation. Global report on trends in prevalence of tobacco use 2000–2025. 3rd ed. Geneva: WHO; 2019.

National Cancer Institute and Centres for Disease Control and Prevention: Smokeless tobacco and public health: A global perspective. Bethesda, MD: U.S. Department of Health and Human Services; 2014.

Benowitz NL, Hukkanen J, Jacob P, III: Nicotine chemistry, metabolism, kinetics and biomarkers. In: Nicotine psychopharmacology. Volume 192, edn. Edited by Henningfield JE, London ED, Pogun S: Springer Berlin Heidelberg; 2009: 29–60.

Ratsch A, Steadman KJ, Bogossian F. The pituri story: a review of the historical literature surrounding traditional Australian Aboriginal use of nicotine in central Australia. J Ethnobiol Ethnomed. 2010;6:26. https://doi.org/10.1186/1746-4269-6-26.CrossRefPubMedPubMedCentral

Moghbel N, Ryu B, Cabot PJ, Ratsch A, Steadman KJ. In vitro cytotoxicity of Nicotiana gossei leaves, used in the Australian Aboriginal smokeless tobacco known as pituri or mingkulpa. Toxicol Lett. 2016;254:45–51. https://doi.org/10.1016/j.toxlet.2016.05.011.CrossRefPubMed

Moghbel N, Ryu B, Ratsch A, Steadman KJ. Nicotine alkaloid levels, and nicotine to nornicotine conversion, in Australian Nicotiana species used as chewing tobacco. Heliyon. 2017;3(11):e00469–e00469. https://doi.org/10.1016/j.heliyon.2017.e00469.CrossRefPubMedPubMedCentral

Wilhelm J, Mishina E, Viray L, Paredes A, Pickworth WB. The pH of smokeless tobacco determines nicotine buccal absorption: results of a randomized crossover trial. Clin Pharmacol Ther. 2021. https://doi.org/10.1002/cpt.2493.CrossRefPubMed

Gupta SK, Benowitz NL, Jacob P 3rd, Rolf CN, Gorsline J. Bioavailability and absorption kinetics of nicotine following application of a transdermal system. Br J Clin Pharmacol. 1993;36(3):221–7. https://doi.org/10.1111/j.1365-2125.1993.tb04221.x.CrossRefPubMedPubMedCentral

Ratsch A, Mason A, Rive L, Bogossian F, Steadman K: The pituri learning story: Central Australian Aboriginal women’s knowledge and practices around the use of Nicotiana spp. As a chewing tobacco. In: Rural Remote Health. vol. July-Sep; 2017: 4044.

10.

Luck W, Nau H. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers. J Pediatr. 1985;107(5):816–20. https://doi.org/10.1016/s0022-3476(85)80427-3.CrossRefPubMed

11.

Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20(2):115–26. https://doi.org/10.1016/s0146-0005(96)80079-6.CrossRefPubMed

12.

Benowitz NL. Clinical pharmacology of nicotine. Annu Rev Med. 1986;37:21–32. https://doi.org/10.1146/annurev.me.37.020186.000321.CrossRefPubMed

13.

Grenhoff J, Svensson TH. Pharmacology of nicotine. Br J Addict. 1989;84(5):477–92. https://doi.org/10.1111/j.1360-0443.1989.tb00604.x.CrossRefPubMed

14.

Benowitz NL, Kuyt F, Jacob P 3rd, Jones RT, Osman AL. Cotinine disposition and effects. Clin Pharmacol Ther. 1983;34(5):604–11. https://doi.org/10.1038/clpt.1983.222.CrossRefPubMed

15.

Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57(1):79–115. https://doi.org/10.1124/pr.57.1.3.CrossRefPubMed

16.

Dempsey D, Jacob P 3rd, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594–8. https://doi.org/10.1124/jpet.301.2.594.CrossRefPubMed

17.

Arger CA, Taghavi T, Heil SH, Skelly J, Tyndale RF, Higgins ST. Pregnancy-induced increases in the nicotine metabolite ratio: examining changes during antepartum and postpartum. Nicotine Tob Res. 2019;21(12):1706–10. https://doi.org/10.1093/ntr/nty172.CrossRefPubMed

18.

Dempsey D, Jacob P 3rd, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther. 2000;67(5):458–65. https://doi.org/10.1067/mcp.2000.106129.CrossRefPubMed

19.

Ratsch A, Bogossian F. Smokeless tobacco use in pregnancy: an integrative review of the literature. Int J Public Health. 2014;59(4):599–608. https://doi.org/10.1007/s00038-014-0558-6.CrossRefPubMed

20.

England LJ, Kim SY, Shapiro-Mendoza CK, Wilson HG, Kendrick JS, Satten GA, Lewis CA, Tucker MJ, Callaghan WM. Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case-control study. Acta Obstet Gynecol Scand. 2013;92(6):648–55. https://doi.org/10.1111/aogs.12124.CrossRefPubMedPubMedCentral

21.

Hossain MS, Kypri K, Rahman B, Milton AH. Smokeless tobacco consumption and stillbirth: Population-based case-control study in rural Bangladesh. Drug Alcohol Rev. 2018;37(3):414–20. https://doi.org/10.1111/dar.12566.CrossRefPubMed

22.

Ganganahalli P, Pratinidhi A, Patil JA, Kakade SV. Smokeless tobacco use & anaemia among pregnant women in Karad Taluk Western Maharashtra: a cross sectional study. Ntl J of Community Med. 2015;6(4):622–5.

23.

Inamdar AS, Croucher RE, Chokhandre MK, Mashyakhy MH, Marinho VC. Maternal smokeless tobacco use in pregnancy and adverse health outcomes in newborns: a systematic review. Nicotine Tob Res. 2015;17(9):1058–66. https://doi.org/10.1093/ntr/ntu255.CrossRefPubMed

24.

Pineles BL, Hsu S, Park E, Samet JM. Systematic review and meta-analyses of perinatal death and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol. 2016;184(2):87–97. https://doi.org/10.1093/aje/kwv301.CrossRefPubMedPubMedCentral

25.

Pineles BL, Park E, Samet JM. Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol. 2014;179(7):807–23. https://doi.org/10.1093/aje/kwt334.CrossRefPubMedPubMedCentral

26.

Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, Stampfer MJ, Speizer FE, Spiegelman D, Manson JE. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278(13):1078–83. https://doi.org/10.1001/jama.1997.03550130052036.CrossRefPubMed

27.

England LJ, Levine RJ, Qian C, Soule LM, Schisterman EF, Yu KF, Catalano PM. Glucose tolerance and risk of gestational diabetes mellitus in nulliparous women who smoke during pregnancy. Am J Epidemiol. 2004;160(12):1205–13. https://doi.org/10.1093/aje/kwh340.CrossRefPubMed

28.

Kim MK, Han K, You SY, Kwon HS, Yoon KH, Lee SH. Prepregnancy smoking and the risk of gestational diabetes requiring insulin therapy. Sci Rep. 2020;10(1):13901. https://doi.org/10.1038/s41598-020-70873-7.CrossRefPubMedPubMedCentral

29.

Rogers JM. Tobacco and pregnancy. Reprod Toxicol. 2009;28(2):152–60. https://doi.org/10.1016/j.reprotox.2009.03.012.CrossRefPubMed

30.

Gonzalez-Quintero VH, Istwan NB, Rhea DJ, Rodriguez LI, Cotter A, Carter J, Mueller A, Stanziano GJ. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care. 2007;30(3):467–70. https://doi.org/10.2337/dc06-1875.CrossRefPubMed

31.

Jones CW. Gestational diabetes and its impact on the neonate. Neonatal Netw. 2001;20(6):17–23. https://doi.org/10.1891/0730-0832.20.6.17.CrossRefPubMed

32.

Pintaudi B, Fresa R, Dalfra M, Dodesini AR, Vitacolonna E, Tumminia A, Sciacca L, Lencioni C, Marcone T, Lucisano G, et al. The risk stratification of adverse neonatal outcomes in women with gestational diabetes (strong) study. Acta Diabetol. 2018;55(12):1261–73. https://doi.org/10.1007/s00592-018-1208-x.CrossRefPubMed

33.

Makgoba M, Savvidou MD, Steer PJ. The effect of maternal characteristics and gestational diabetes on birthweight. BJOG. 2012;119(9):1091–7. https://doi.org/10.1111/j.1471-0528.2012.03388.x.CrossRefPubMed

34.

Tracy SK, Tracy MB, Sullivan E. Admission of term infants to neonatal intensive care: a population-based study. Birth. 2007;34(4):301–7. https://doi.org/10.1111/j.1523-536X.2007.00188.x.CrossRefPubMed

35.

Slotkin T: Expert opinions: Nicotine: Interview with Professor Theodore Slotkin. In: ABC Online - Quantum. Australia: Australia Broadcasting Corporation; 1997.

36.

England LJ, Aagaard K, Bloch M, Conway K, Cosgrove K, Grana R, Gould TJ, Hatsukami D, Jensen F, Kandel D, et al. Developmental toxicity of nicotine: a transdisciplinary synthesis and implications for emerging tobacco products. Neurosci Biobehav Rev. 2017;72:176–89. https://doi.org/10.1016/j.neubiorev.2016.11.013.CrossRefPubMed

37.

Slotkin TA, Lappi SE, McCook EC, Lorber BA, Seidler FJ. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull. 1995;38(1):69–75. https://doi.org/10.1016/0361-9230(95)00073-n.CrossRefPubMed

38.

Shapiro-Mendoza CK, Parks S, Lambert AE, Camperlengo L, Cottengim C, Olson C: The epidemiology of sudden infant death syndrome and sudden unexpected infant deaths: Diagnostic shift and other temporal changes: University of Adelaide Press, Adelaide (AU); 2018.

39.

eTG. Therapeutic guidelines 2015 [cited June 10 2015].[Available from: https://www.tg.org.au/etg_demo/desktop/tgc/plg/breastfeeding_n.htm]

40.

U.S. Food & Drug Administration. Tobacco products 2021 [cited 21 September 2021].[Available from: https://www.fda.gov/tobacco-products]

41.

Therapeutic Goods Administration. Category D drugs 2015 [cited May 10 2016].[Available from: http://www.tga.gov.au/prescribing-medicines-pregnancy-database]

42.

Cornelius MD, Goldschmidt L, Day NL. Prenatal cigarette smoking: long-term effects on young adult behavior problems and smoking behavior. Neurotoxicol Teratol. 2012;34(6):554–9. https://doi.org/10.1016/j.ntt.2012.09.003.CrossRefPubMedPubMedCentral

43.

Berlin I, Oncken C. Maternal smoking during pregnancy and negative health outcomes in the offspring. Nicotine Tob Res. 2018;20(6):663–4. https://doi.org/10.1093/ntr/nty035.CrossRefPubMed

44.

Kataria Y, Gaewsky L, Ellervik C. Prenatal smoking exposure and cardio-metabolic risk factors in adulthood: a general population study and a meta-analysis. Int J Obes (Lond). 2019;43(4):763–73. https://doi.org/10.1038/s41366-018-0206-y.CrossRefPubMed

45.

Lawder R, Whyte B, Wood R, Fischbacher C, Tappin DM. Impact of maternal smoking on early childhood health: a retrospective cohort linked dataset analysis of 697 003 children born in Scotland 1997–2009. BMJ Open. 2019;9(3): e023213. https://doi.org/10.1136/bmjopen-2018-023213.CrossRefPubMedPubMedCentral

46.

Mittal S. Smoking and tobacco use: Ill effects on reproductive, maternal, newborn, child health, and adolescent (rmncha) program—a review. Ann Natl Acad Med Sci. 2019;55(02):065–73. https://doi.org/10.1055/s-0039-1694071.CrossRef

47.

Australian Institute of Health and Welfare: National perinatal data collection (NPDC), vol. 2020. Canberra: Australian Government; 2020.

48.

Australian Institute of Health and Welfare. Australia's mothers and babies 2021 [cited 8 July 2021].[Available from: https://www.aihw.gov.au/reports/mothers-babies/australias-mothers-babies-data-visualisations/contents/antenatal-period/smoking]

49.

Zhang X, Johnstone K: Northern Territory midwives’ collection. Mothers and babies 2005. Darwin: Department of Health and Families; 2009.

50.

Li L, O’Neil L: Mothers and babies 2016: Northern Territory midwives’ collection. Darwin: Department of Health; 2019.

51.

Australian Institute of Health and Welfare: Australia's mothers and babies 2013 in brief. Canberra: AIHW; 2015.

52.

Hall J, Case A, O'Neil L: Northern Territory midwives’ collection. Mothers and babies 2013. Darwin: Health Gains Planning Branch; 2015.

53.

Australian Institute of Health and Welfare. National Indigenous Australian Agency. Aboriginal and Torres Strait Islander health performance framework 2021 [cited 20 October2021].[Available from: https://www.indigenoushpf.gov.au/measures/1-01-low-birthweight]

54.

Ratsch A, Bogossian F, Steadman K. Central Australian Aboriginal women’s pregnancy, labour and birth outcomes following maternal smokeless tobacco (pituri) use, cigarette use or no-tobacco use: a prospective cohort study. BMC Public Health. 2021;21(1):814. https://doi.org/10.1186/s12889-021-10872-z.CrossRefPubMedPubMedCentral

55.

Ratsch A, Bogossian F, Burmeister EA, Steadman K: Central Australian Aboriginal women's placental and neonatal outcomes following maternal smokeless tobacco, cigarette or no tobacco use. Aust N Z J Public Health. 2021; . doi:https://doi.org/10.1111/1753-6405.13186

56.

Ratsch A, Steadman K, Ryu B, Bogossian F. Tobacco and pituri use in pregnancy: a protocol for measuring maternal and perinatal exposure and outcomes in central Australian Aboriginal women. Methods Protoc. 2019;2(2):47. https://doi.org/10.3390/mps2020047.CrossRefPubMedPubMedCentral

57.

Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, Enoch CC, Gill L, Angstman SE, Moyer TP. Iqmik–a form of smokeless tobacco used by pregnant alaska natives: nicotine exposure in their neonates. J Matern Fetal Neonatal Med. 2005;17(4):281–9. https://doi.org/10.1080/14767050500123731.CrossRefPubMed

58.

Li Z, Zeki R, Hilder L, Sullivan E: Australia's mothers and babies 2011. Canberra: Australian Institute of Health and Welfare; 2013.

59.

Thompson F: Northern Territory midwives’ collection. Mothers and babies 2011. Darwin: Department of Health; 2014.

60.

Health Gains Planning Unit: Central Australian Regional Plan (2010–2012) 2012.

61.

Benowitz N, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clinical Pharmacology Therapy. 1988;44(1):23–8.CrossRef

62.

George L, Granath F, Johansson AL, Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand. 2006;85(11):1331–7. https://doi.org/10.1080/00016340600935433.CrossRefPubMed

63.

World Health Organization. Smokeless tobacco and some tobacco-specific n-nitrosamines, vol. 89. Lyon, France: WHO; 2007.

64.

Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther. 1985;8(6):384–95. https://doi.org/10.1159/000457063.CrossRefPubMed

65.

Habek D, Habek JC, Ivanisevic M, Djelmis J. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn Ther. 2002;17(6):367–71. https://doi.org/10.1159/000065387.CrossRefPubMed

66.

Dahlstrom A, Ebersjo C, Lundell B. Nicotine exposure in breastfed infants. Acta Paediatr. 2004;93(6):810–6. https://doi.org/10.1111/j.1651-2227.2004.tb03023.x.CrossRefPubMed

67.

Steldinger R, Luck W, Nau H. Half lives of nicotine in milk of smoking mothers: implications for nursing. J Perinat Med. 1988;16(3):261–2.PubMed

68.

Benowitz NL, Dains KM, Dempsey D, Yu L, Jacob P 3rd. Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1160–6. https://doi.org/10.1158/1055-9965.EPI-09-1303.CrossRefPubMedPubMedCentral

69.

University of California San Franciso. Analysis of below detectable biomarker lab values 2022 [cited [Available from: https://khrc.ucsf.edu/analysis-below-detectable-biomarker-lab-values]

70.

The National Health and Medical Research Council, the Australian Research Council, and Universities Australia: National statement on ethical conduct in human research 2007 (updated 2018). Canberra: Commonwealth of Australia; 2018.

71.

Gilligan C, Sanson-Fisher R, Eades S, Wenitong M, Panaretto K, D’Este C. Assessing the accuracy of self-reported smoking status and impact of passive smoke exposure among pregnant Aboriginal and Torres Strait Islander women using cotinine biochemical validation. Drug Alcohol Rev. 2010;29(1):35–40. https://doi.org/10.1111/j.1465-3362.2009.00078.x.CrossRefPubMed

72.

Aurrekoetxea JJ, Murcia M, Rebagliato M, Lopez MJ, Castilla AM, Santa-Marina L, Guxens M, Fernandez-Somoano A, Espada M, Lertxundi A, et al. Determinants of self-reported smoking and misclassification during pregnancy, and analysis of optimal cut-off points for urinary cotinine: a cross-sectional study. BMJ Open. 2013;3(1): e002034. https://doi.org/10.1136/bmjopen-2012-002034.CrossRefPubMedPubMedCentral

73.

Stragierowicz J, Mikolajewska K, Zawadzka-Stolarz M, Polanska K, Ligocka D. Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland. Biomed Res Int. 2013;2013: 386784. https://doi.org/10.1155/2013/386784.CrossRefPubMedPubMedCentral

74.

Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280(2):152–6. https://doi.org/10.1001/jama.280.2.152.CrossRefPubMed

75.

Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Eriksen MP, Pirkle JL, Maurer KR. Racial and ethnic differences in serum cotinine levels of cigarette smokers: third national health and nutrition examination survey, 1988–1991. JAMA. 1998;280(2):135–9. https://doi.org/10.1001/jama.280.2.135.CrossRefPubMed

76.

Wang H, Park SL, Stram DO, Haiman CA, Wilkens LR, Hecht SS, Kolonel LN, Murphy SE, Le Marchand L. Associations between genetic ancestries and nicotine metabolism biomarkers in the multiethnic cohort study. Am J Epidemiol. 2015;182(11):945–51. https://doi.org/10.1093/aje/kwv138.CrossRefPubMedPubMedCentral

77.

Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017;184:101–7. https://doi.org/10.1016/j.trsl.2017.02.004.CrossRefPubMedPubMedCentral

78.

Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654–64. https://doi.org/10.1001/jama.298.22.2654.CrossRefPubMed

79.

Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE: Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30 Suppl 2(Supplement 2):S112–119. doi:https://doi.org/10.2337/dc07-s202

80.

Voaklander B, Rowe S, Sanni O, Campbell S, Eurich D, Ospina MB. Prevalence of diabetes in pregnancy among Indigenous women in Australia, Canada, New Zealand, and the USA: a systematic review and meta-analysis. Lancet Glob Health. 2020;8(5):e681–98. https://doi.org/10.1016/s2214-109x(20)30046-2.CrossRefPubMed

81.

Australian Institute of Health and Welfare: Australia's mothers and babies data visualisations. Cat. No. Per 101. Canberra: AIHW; 2020.

82.

Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59(7):1396–9. https://doi.org/10.1007/s00125-016-3985-5.CrossRefPubMed

83.

Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181(4):1026–35. https://doi.org/10.1016/s0002-9378(99)70341-8.CrossRefPubMed

84.

Karumanchi SA, Levine RJ. How does smoking reduce the risk of preeclampsia? Hypertension. 2010;55(5):1100–1. https://doi.org/10.1161/HYPERTENSIONAHA.109.148973.CrossRefPubMed

85.

England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci. 2007;12:2471–83. https://doi.org/10.2741/2248.CrossRefPubMed

86.

Subramoney S, Gupta PC. Anemia in pregnant women who use smokeless tobacco. Nicotine Tob Res. 2008;10(5):917–20. https://doi.org/10.1080/14622200802027206.CrossRefPubMed

87.

Pratinidhi A, Gandham S, Shrotri A, Patil A, Pardeshi S. Use of “mishri” a smokeless form of tobacco during pregnancy and its perinatal outcome. Indian J Community Med. 2010;35(1):14–8. https://doi.org/10.4103/0970-0218.62547.CrossRefPubMedPubMedCentral

88.

Capra L, Tezza G, Mazzei F, Boner AL. The origins of health and disease: the influence of maternal diseases and lifestyle during gestation. Ital J Pediatr. 2013;39(1):7. https://doi.org/10.1186/1824-7288-39-7.CrossRefPubMedPubMedCentral

89.

Willcocks B, McAuliffe GN, Baird RW. Dwarf tapeworm (Hymenolepis nana): characteristics in the Northern Territory 2002–2013. J Paediatr Child Health. 2015;51(10):982–7. https://doi.org/10.1111/jpc.12885.CrossRefPubMed

90.

Roulette CJ, Mann H, Kemp BM, Remiker M, Roulette JW, Hewlett BS, Kazanji M, Breurec S, Monchy D, Sullivan RJ, et al. Tobacco use vs. Helminths in Congo basin hunter-gatherers: self-medication in humans? Evol Hum Behav. 2014;35(5):397–407.CrossRef

91.

Stewart GG. A history of the medicinal use of tobacco 1492–1860. Med Hist. 1967;11(3):228–68.CrossRefPubMedPubMedCentral

92.

Berlowitz I, Torres EG, Walt H, Wolf U, Maake C, Martin-Soelch C. “Tobacco is the chief medicinal plant in my work”: Therapeutic uses of tobacco in Peruvian Amazonian medicine exemplified by the work of a Maestro Tabaquero. Front Pharmacol. 2020;11(1600): 594591. https://doi.org/10.3389/fphar.2020.594591.CrossRefPubMedPubMedCentral

93.

Sastry BV, Chance MB, Hemontolor ME, Goddijn-Wessel TA. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology. 1998;57(2):104–16. https://doi.org/10.1159/000028231.CrossRefPubMed

94.

Bruin JE, Kellenberger LD, Gerstein HC, Morrison KM, Holloway AC. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: Identifying critical windows of exposure. J Endocrinol. 2007;194(1):171–8. https://doi.org/10.1677/JOE-07-0050.CrossRefPubMed

95.

Holloway AC, Lim GE, Petrik JJ, Foster WG, Morrison KM, Gerstein HC. Fetal and neonatal exposure to nicotine in wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes. Diabetologia. 2005;48(12):2661–6. https://doi.org/10.1007/s00125-005-0022-5.CrossRefPubMed

96.

von Kries R, Toschke AM, Koletzko B, Slikker W Jr. Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol. 2002;156(10):954–61. https://doi.org/10.1093/aje/kwf128.CrossRef

97.

Kamiya M, Suzuki K, Yamagata Z. Effect of maternal active smoking during pregnancy on the trajectory of childhood body mass index: a multilevel analysis using quartiles of birthweight. Tob Induc Dis. 2020;18:34. https://doi.org/10.18332/tid/119117.CrossRefPubMedPubMedCentral

98.

Nordenstam F, Lundell B, Edstedt Bonamy AK, Raaschou P, Wickstrom R. Snus users had high levels of nicotine, cotinine and 3-hydroxycotinine in their breastmilk, and the clearance was slower than in smoking mothers. Acta Paediatr. 2019;108(7):1250–5. https://doi.org/10.1111/apa.14602.CrossRefPubMed

99.

Gao YJ, Holloway AC, Su LY, Takemori K, Lu C, Lee RM. Effects of fetal and neonatal exposure to nicotine on blood pressure and perivascular adipose tissue function in adult life. Eur J Pharmacol. 2008;590(1–3):264–8. https://doi.org/10.1016/j.ejphar.2008.05.044.CrossRefPubMed

100.

Borowitz JL, Isom GE. Nicotine and type 2 diabetes. Toxicol Sci. 2008;103(2):225–7. https://doi.org/10.1093/toxsci/kfn050.CrossRefPubMed

101.

Kohler E, Bretschneider D, Rabsilber A, Weise W, Jorch G. Assessment of prenatal smoke exposure by determining nicotine and its metabolites in maternal and neonatal urine. Hum Exp Toxicol. 2001;20(1):1–7. https://doi.org/10.1191/096032701669841404.CrossRefPubMed

102.

Luck W, Nau H. Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br J Clin Pharmacol. 1984;18(1):9–15. https://doi.org/10.1111/j.1365-2125.1984.tb05014.x.CrossRefPubMedPubMedCentral

103.

Tayie FA, Powell C. Sex differences in the association between prenatal smoking and decreased birthweight, and intensive health care of the neonate. Behav Med. 2012;38(4):138–42. https://doi.org/10.1080/08964289.2012.703977.CrossRefPubMed

104.

Fukuda M, Fukuda K, Shimizu T, Andersen CY, Byskov AG. Parental periconceptional smoking and male: female ratio of newborn infants. Lancet. 2002;359(9315):1407–8. https://doi.org/10.1016/S0140-6736(02)08362-9.CrossRefPubMed

105.

Koshy G, Delpisheh A, Brabin BJ. Parental smoking and increased likelihood of female birth. Arch Dis Child. 2008;93(Suppl 2):ps531–ps531.

106.

Khan UA, Adil MM: Effect of number of cigarettes daily consumed on offspring sex ratio. In: Medical management of chemical and biological casualties. edn. Edited by Tonev S, Kanev K, Dishovsky C. Sofia: Military Medical Academy; 2009: 189–196.

107.

World Bank Group. Sex ratio at birth (male births per female births) 2018 [cited 18 July 2021].[Available from: https://data.worldbank.org/indicator/SP.POP.BRTH.MF]

108.

Nakamura A, Francois O, Lepeule J. Epigenetic alterations of maternal tobacco smoking during pregnancy: a narrative review. Int J Environ Res Public Health. 2021;18(10):5083. https://doi.org/10.3390/ijerph18105083.CrossRefPubMedPubMedCentral

109.

Cnattingius S: The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;6 Suppl 2(Suppl 2):S125–140. doi:https://doi.org/10.1080/14622200410001669187

110.

Baba S, Wikstrom AK, Stephansson O, Cnattingius S. Changes in snuff and smoking habits in Swedish pregnant women and risk for small for gestational age births. BJOG. 2013;120(4):456–62. https://doi.org/10.1111/1471-0528.12067.CrossRefPubMed

111.

Porter C, Skinner T, Ellis I. What is the impact of diabetes for Australian Aboriginal women when pregnant? Diabetes Res Clin Pract. 2011;93(1):e29-32. https://doi.org/10.1016/j.diabres.2011.03.013.CrossRef

112.

Ahmed MA, Bailey HD, Pereira G, White SW, Wong K, Shepherd CCJ. Trends and burden of diabetes in pregnancy among Aboriginal and non-Aboriginal mothers in Western Australia, 1998–2015. BMC Public Health. 2022;22(1):263. https://doi.org/10.1186/s12889-022-12663-6.CrossRefPubMedPubMedCentral

Title: Higher blood nicotine concentrations following smokeless tobacco (pituri) and cigarette use linked to adverse pregnancy outcomes for Central Australian Aboriginal pregnancies
Authors: Angela Ratsch
Fiona Bogossian
Elizabeth A. Burmeister
BoMi Ryu
Kathryn J. Steadman
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-022-14609-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Higher blood nicotine concentrations following smokeless tobacco (pituri) and cigarette use linked to adverse pregnancy outcomes for Central Australian Aboriginal pregnancies

Abstract

Background

Methods

Results

Conclusions

Note to readers

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Note to readers

Please log in to get access to this content

Other articles of this Issue 1/2022

Effects of globalization, energy consumption and ICT on health status in Australia: the role of financial development and education

The COVID-19 pandemic’s intersectional impact on work life, home life and wellbeing: an exploratory mixed-methods analysis of Georgia women’s experiences during the pandemic

The cultural adaptation of the go wish card game for use in Flanders, Belgium: a public health tool to identify and discuss end-of-life preferences

Sleep duration and risk of high blood pressure in Thai adolescents: the Thai National Health Examination Survey V, 2014 (NHES-V)

Qualitative comparative analysis of the implementation fidelity of a workplace sedentary reduction intervention

Variation of parental feeding practices during the COVID-2019 pandemic: a systematic review